Page 211 - Tata Chemical Annual Report_2022-2023

Integrated Annual Report 2022-23 01-83 84-192 193-365
Integrated Report Statutory Reports Financial Statements
Standalone

` in crore 255 255 ` in crore Total 13,002 802 - 1,538 2,340 (255) - 15,087 1,027 - (59) 968 (318) - 15,737 Standalone Statement of Cash Flows for the year ended March 31, 2023
Standalone Statement of Changes in Equity for the year ended March 31, 2023
` in crore
Year ended
Year ended
Particulars
March 31, 2023
March 31, 2022
Items of Other Comprehensive Income Equity instruments through Other Comprehensive Income 2,731 1,521 1,521 4,252 (65) (65) 4,187 Managing Director and CEO Chief Financial Officer Chief General Counsel & Company Secretary A Cash flows from operating activities 1,265 1,016

988
Profit before tax from continuing operations
1,265
-
28
Profit before tax from discontinued operations

Adjustments for :

222
245
19
Finance costs
26
Retained earnings ** 6,078 802 17 819 (255) 6,642 1,027 6 1,033 (318) 7,357 Chairman Director Depreciation and amortisation expense (162) (110)
Interest income
(61)
Dividend income
(83)
General reserve 1,412 - - - - 1,412 - - - - 1,412 For and on behalf of the Board N. Chandrasekaran (DIN: 00121863) Padmini Khare Kaicker (DIN: 00296388) R. Mukundan (DIN: 00778253) Nandakumar S. Tirumalai (ICAI M. No.: 203896) Rajiv Chandan (ICSI M. No.: FCS 4312) Net gain on sale of current investments (54) (46)
8
21
Provision for employee benefits expense
Provision for doubtful debts and advances/bad debts written off (net)
(1)
1
23
Provision for contingencies (net)
14
Reserves and surplus Capital redemption reserve * - - - - * - - - - * Liabilities no longer required written back 1,309 1,038
(2)
(1)
(5)
Foreign exchange (gain)/loss (net)
3
5
4
Loss on assets sold or discarded (net)
** Includes balance of remeasurement of net loss on defined benefit plans of ` 22 crore (2022: ` 29 crore).
Operating profit before working capital changes
Securities premium 1,258 - - - - 1,258 - - - - 1,258 Adjustments for : (324) (358)
Trade receivables, other financial assets and other assets
40
20
Inventories
141
67
Capital reserve and other reserves from amalgamation 1,523 - - - - 1,523 - - - - 1,523 Trade payables, other financial liabilities and other liabilities 1,166 (185)
Cash generated from operations
767
Taxes paid (net of refund)
(281)

Cash flows from investing activities
B Net cash generated from operating activities 885 582
Acquisition of property, plant and equipment (including capital work-in-progress) (946) (776)
Acquisition of intangible assets (including intangible asset under development) (1) (8)
Proceeds from sale of property, plant and equipment 1 7
Proceeds from sale of other non-current investments (3,349) (4,229)
150
75
4,444
Proceeds from sale of current investments
3,506
Equity share capital (note 15) Balance as at March 31, 2023 Balance as at March 31, 2022 Other equity (note 16) Balance as at 1 April, 2021 Other Comprehensive Income (net of tax) Total Comprehensive Income for the year Balance as at March 31, 2022 Other Comprehensive Income (net of tax) Total Comprehensive Income for the year Balance as at March 31, 2023 Notes 1 to 43 are an integral part of these Standalone Financial Statements As per our report of even d
(150)
Purchase of non-current investments
(133)

Purchase of current investments
-
(39)

402
Bank balances not considered as cash and cash equivalents (net)
-
Loans - Inter-corporate deposit placed

34
31
Interest received
Dividend received
29
29
From subsidiaries
-
92
28
From others
-
26
41
Net cash used in investing activities
a Particulars b Particulars Profit for the year Dividends Profit for the year Dividends * value below ` 0.50 crore For B S R & Co. LLP Chartered Accountants Vijay Mathur Partner Membership No. 046476 Mumbai, May 3, 2023 - From joint venture (558) (355)
208 209